Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bulimia | 38 | 2021 | 400 | 3.470 |
Why?
|
Bulimia Nervosa | 7 | 2018 | 206 | 2.080 |
Why?
|
Anorexia Nervosa | 36 | 2017 | 1361 | 1.510 |
Why?
|
Satiation | 4 | 2018 | 83 | 1.270 |
Why?
|
Binge-Eating Disorder | 2 | 2021 | 147 | 0.760 |
Why?
|
Serotonin | 14 | 2004 | 1041 | 0.700 |
Why?
|
Gastroparesis | 1 | 2021 | 136 | 0.660 |
Why?
|
Norepinephrine | 40 | 1994 | 897 | 0.590 |
Why?
|
Methoxyhydroxyphenylglycol | 39 | 1993 | 93 | 0.580 |
Why?
|
Peptide YY | 1 | 2017 | 136 | 0.560 |
Why?
|
Leptin | 5 | 2010 | 1597 | 0.470 |
Why?
|
Glycols | 18 | 1988 | 55 | 0.460 |
Why?
|
Serotonin Receptor Agonists | 3 | 2000 | 151 | 0.400 |
Why?
|
Family Practice | 1 | 2015 | 512 | 0.390 |
Why?
|
Prolactin | 11 | 2000 | 625 | 0.390 |
Why?
|
Tryptophan | 5 | 2000 | 482 | 0.360 |
Why?
|
Cholecystokinin | 2 | 2007 | 117 | 0.340 |
Why?
|
Psychotherapy | 3 | 2015 | 1647 | 0.340 |
Why?
|
Amylases | 3 | 2011 | 171 | 0.340 |
Why?
|
Ghrelin | 1 | 2010 | 252 | 0.320 |
Why?
|
Eating | 8 | 2010 | 1539 | 0.300 |
Why?
|
Receptors, Serotonin | 6 | 1997 | 208 | 0.280 |
Why?
|
Convalescence | 1 | 2007 | 105 | 0.280 |
Why?
|
Body Weight | 26 | 2016 | 4618 | 0.270 |
Why?
|
Depressive Disorder | 26 | 1993 | 3728 | 0.270 |
Why?
|
Depression | 16 | 2016 | 8126 | 0.260 |
Why?
|
Postprandial Period | 1 | 2007 | 315 | 0.250 |
Why?
|
Fenfluramine | 5 | 2000 | 58 | 0.250 |
Why?
|
Vomiting | 3 | 2007 | 651 | 0.240 |
Why?
|
Feeding Behavior | 8 | 2010 | 3188 | 0.240 |
Why?
|
Hydrocortisone | 21 | 1996 | 1819 | 0.240 |
Why?
|
Disease Management | 1 | 2015 | 2508 | 0.230 |
Why?
|
Neurotransmitter Agents | 4 | 2003 | 665 | 0.220 |
Why?
|
Piperazines | 7 | 1996 | 2523 | 0.210 |
Why?
|
Basal Metabolism | 2 | 1994 | 161 | 0.200 |
Why?
|
Affective Symptoms | 6 | 1994 | 417 | 0.200 |
Why?
|
Amino Acids | 2 | 2000 | 1718 | 0.190 |
Why?
|
Receptors, Adrenergic | 8 | 1990 | 155 | 0.190 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2001 | 109 | 0.180 |
Why?
|
Diet, Reducing | 3 | 2004 | 485 | 0.180 |
Why?
|
Neuropeptides | 2 | 2004 | 944 | 0.170 |
Why?
|
Nervous System | 2 | 2002 | 545 | 0.170 |
Why?
|
Family | 1 | 2010 | 3195 | 0.170 |
Why?
|
Emotions | 5 | 2010 | 2739 | 0.170 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2015 | 1988 | 0.170 |
Why?
|
Gastric Emptying | 1 | 2021 | 242 | 0.160 |
Why?
|
Obsessive-Compulsive Disorder | 4 | 2007 | 1491 | 0.160 |
Why?
|
Homovanillic Acid | 11 | 1993 | 75 | 0.160 |
Why?
|
Adult | 91 | 2017 | 221210 | 0.150 |
Why?
|
Lactates | 3 | 1987 | 405 | 0.150 |
Why?
|
Female | 101 | 2021 | 392705 | 0.150 |
Why?
|
Salivary Glands | 1 | 1999 | 229 | 0.150 |
Why?
|
Reversal Learning | 1 | 2017 | 57 | 0.140 |
Why?
|
Imagination | 1 | 1997 | 226 | 0.130 |
Why?
|
Clonidine | 11 | 1985 | 169 | 0.130 |
Why?
|
Hydroxyindoleacetic Acid | 8 | 1997 | 93 | 0.130 |
Why?
|
Weight Gain | 2 | 1997 | 2348 | 0.130 |
Why?
|
Isoproterenol | 3 | 1990 | 395 | 0.130 |
Why?
|
Humans | 144 | 2021 | 761596 | 0.120 |
Why?
|
Body Mass Index | 6 | 2016 | 12953 | 0.110 |
Why?
|
Case-Control Studies | 6 | 2021 | 22176 | 0.110 |
Why?
|
Energy Intake | 7 | 1994 | 2134 | 0.110 |
Why?
|
Taste | 1 | 1994 | 189 | 0.110 |
Why?
|
Placebos | 7 | 2016 | 1667 | 0.110 |
Why?
|
Nutritional Status | 3 | 1997 | 1615 | 0.110 |
Why?
|
Psychological Tests | 2 | 2017 | 640 | 0.110 |
Why?
|
Carbamazepine | 3 | 1991 | 224 | 0.100 |
Why?
|
Dopamine | 6 | 1992 | 1607 | 0.100 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2016 | 602 | 0.100 |
Why?
|
Antidepressive Agents | 5 | 1996 | 2897 | 0.100 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2016 | 6019 | 0.100 |
Why?
|
Personality Inventory | 5 | 2007 | 1019 | 0.100 |
Why?
|
Corticotropin-Releasing Hormone | 6 | 1989 | 361 | 0.100 |
Why?
|
Drug Delivery Systems | 1 | 2003 | 2226 | 0.090 |
Why?
|
Hunger | 2 | 2007 | 206 | 0.090 |
Why?
|
Food Preferences | 1 | 1994 | 398 | 0.090 |
Why?
|
Dynorphins | 1 | 1991 | 82 | 0.090 |
Why?
|
Satiety Response | 2 | 2004 | 47 | 0.090 |
Why?
|
Thyroid Function Tests | 1 | 1991 | 288 | 0.090 |
Why?
|
Growth Hormone | 8 | 1985 | 569 | 0.090 |
Why?
|
Reference Values | 6 | 2007 | 4920 | 0.080 |
Why?
|
Arousal | 3 | 1990 | 1166 | 0.080 |
Why?
|
Social Environment | 1 | 2015 | 1020 | 0.080 |
Why?
|
Young Adult | 6 | 2018 | 59260 | 0.080 |
Why?
|
Dexamethasone | 7 | 1993 | 1948 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2003 | 3530 | 0.080 |
Why?
|
Bipolar Disorder | 18 | 1987 | 5092 | 0.080 |
Why?
|
Adolescent | 18 | 2017 | 88326 | 0.080 |
Why?
|
Brain | 11 | 2007 | 27121 | 0.080 |
Why?
|
Analysis of Variance | 6 | 2017 | 6228 | 0.080 |
Why?
|
Fasting | 3 | 2010 | 1603 | 0.080 |
Why?
|
Psychotropic Drugs | 1 | 1993 | 888 | 0.070 |
Why?
|
Chlorides | 2 | 1989 | 665 | 0.070 |
Why?
|
Migraine Disorders | 2 | 1992 | 1703 | 0.070 |
Why?
|
Double-Blind Method | 15 | 2016 | 12341 | 0.070 |
Why?
|
Control Groups | 1 | 2007 | 104 | 0.070 |
Why?
|
Catecholamines | 5 | 1985 | 386 | 0.070 |
Why?
|
Body Composition | 5 | 2000 | 2426 | 0.070 |
Why?
|
Twins | 3 | 1983 | 339 | 0.070 |
Why?
|
Twins, Monozygotic | 3 | 1983 | 470 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2979 | 0.060 |
Why?
|
Appetite | 1 | 2007 | 247 | 0.060 |
Why?
|
Social Adjustment | 1 | 2007 | 632 | 0.060 |
Why?
|
Schizophrenia | 9 | 1988 | 6937 | 0.060 |
Why?
|
Epinephrine | 4 | 1990 | 792 | 0.060 |
Why?
|
Hormones, Ectopic | 1 | 2004 | 37 | 0.060 |
Why?
|
Social Support | 1 | 2015 | 2172 | 0.060 |
Why?
|
Phenylacetates | 3 | 1982 | 112 | 0.060 |
Why?
|
Apomorphine | 1 | 1984 | 149 | 0.060 |
Why?
|
Hypothalamus | 2 | 2004 | 999 | 0.060 |
Why?
|
Panic | 4 | 1988 | 103 | 0.060 |
Why?
|
Prevalence | 3 | 2007 | 15733 | 0.060 |
Why?
|
Mass Screening | 2 | 2015 | 5429 | 0.060 |
Why?
|
Thyroid Hormones | 3 | 2004 | 404 | 0.060 |
Why?
|
Hormones | 3 | 2000 | 869 | 0.050 |
Why?
|
Interpersonal Relations | 1 | 2010 | 1436 | 0.050 |
Why?
|
Adrenal Glands | 2 | 1987 | 552 | 0.050 |
Why?
|
Tyramine | 5 | 1985 | 53 | 0.050 |
Why?
|
Anxiety Disorders | 4 | 1987 | 2720 | 0.050 |
Why?
|
Proteins | 1 | 1997 | 6032 | 0.050 |
Why?
|
Diazepam | 2 | 1984 | 215 | 0.050 |
Why?
|
Piribedil | 6 | 1984 | 6 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2007 | 3415 | 0.050 |
Why?
|
Self Concept | 1 | 2008 | 1045 | 0.050 |
Why?
|
Attitude to Health | 1 | 2010 | 2025 | 0.050 |
Why?
|
Vanilmandelic Acid | 5 | 1986 | 17 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 9 | 1997 | 10766 | 0.050 |
Why?
|
Stimulation, Chemical | 3 | 1997 | 306 | 0.050 |
Why?
|
Education | 1 | 2004 | 537 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha | 4 | 1985 | 146 | 0.050 |
Why?
|
Hypothalamo-Hypophyseal System | 5 | 1996 | 701 | 0.050 |
Why?
|
Anxiety | 7 | 2017 | 4573 | 0.050 |
Why?
|
Hyperphagia | 3 | 1994 | 139 | 0.050 |
Why?
|
Mood Disorders | 5 | 1989 | 1127 | 0.040 |
Why?
|
Energy Metabolism | 2 | 1991 | 2882 | 0.040 |
Why?
|
Follicular Phase | 1 | 2000 | 143 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2007 | 15843 | 0.040 |
Why?
|
Neural Pathways | 2 | 2004 | 3060 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 2007 | 12973 | 0.040 |
Why?
|
Blood Pressure | 13 | 2007 | 8481 | 0.040 |
Why?
|
Peptide Fragments | 3 | 1991 | 5112 | 0.040 |
Why?
|
Restraint, Physical | 1 | 1981 | 187 | 0.040 |
Why?
|
Receptors, Cell Surface | 2 | 2004 | 2822 | 0.040 |
Why?
|
Sympathetic Nervous System | 5 | 1990 | 518 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7391 | 0.040 |
Why?
|
Comorbidity | 2 | 2007 | 10508 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1651 | 0.040 |
Why?
|
Linear Models | 2 | 1999 | 5872 | 0.030 |
Why?
|
Probenecid | 6 | 1980 | 73 | 0.030 |
Why?
|
beta-Endorphin | 4 | 1993 | 43 | 0.030 |
Why?
|
Radioimmunoassay | 3 | 1994 | 861 | 0.030 |
Why?
|
Mental Disorders | 3 | 1989 | 6845 | 0.030 |
Why?
|
Circadian Rhythm | 5 | 1992 | 2576 | 0.030 |
Why?
|
Hemoglobins | 1 | 2001 | 1526 | 0.030 |
Why?
|
Middle Aged | 29 | 2017 | 220921 | 0.030 |
Why?
|
Taste Threshold | 1 | 1994 | 7 | 0.030 |
Why?
|
Male | 48 | 2015 | 360846 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 4 | 1993 | 618 | 0.030 |
Why?
|
Melatonin | 2 | 1978 | 669 | 0.030 |
Why?
|
Dextroamphetamine | 3 | 1982 | 134 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10721 | 0.030 |
Why?
|
Body Temperature Regulation | 1 | 1996 | 292 | 0.030 |
Why?
|
Hydroxydopamines | 1 | 1973 | 59 | 0.030 |
Why?
|
Aggression | 2 | 1982 | 750 | 0.030 |
Why?
|
Sucrose | 1 | 1994 | 158 | 0.030 |
Why?
|
Hypnosis | 1 | 1994 | 82 | 0.030 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1994 | 139 | 0.030 |
Why?
|
Pulse | 3 | 1990 | 217 | 0.030 |
Why?
|
Clorgyline | 3 | 1983 | 14 | 0.030 |
Why?
|
Fear | 3 | 1988 | 1477 | 0.030 |
Why?
|
Single-Blind Method | 1 | 1997 | 1574 | 0.030 |
Why?
|
Stress, Physiological | 1 | 1981 | 1403 | 0.030 |
Why?
|
Antidepressive Agents, Tricyclic | 3 | 1984 | 432 | 0.030 |
Why?
|
Paroxetine | 1 | 1993 | 182 | 0.030 |
Why?
|
Endorphins | 2 | 1991 | 74 | 0.030 |
Why?
|
Affective Disorders, Psychotic | 2 | 1985 | 186 | 0.030 |
Why?
|
Running | 1 | 2017 | 488 | 0.030 |
Why?
|
Internal-External Control | 1 | 1994 | 358 | 0.030 |
Why?
|
Dissociative Disorders | 1 | 1994 | 234 | 0.030 |
Why?
|
Health Promotion | 1 | 2004 | 2214 | 0.020 |
Why?
|
Lactic Acid | 2 | 1987 | 1139 | 0.020 |
Why?
|
Impulsive Behavior | 1 | 1994 | 346 | 0.020 |
Why?
|
Calorimetry | 1 | 1991 | 129 | 0.020 |
Why?
|
Sleep Deprivation | 2 | 1979 | 846 | 0.020 |
Why?
|
Pituitary-Adrenal System | 4 | 1988 | 552 | 0.020 |
Why?
|
Verbal Learning | 1 | 1993 | 463 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 1991 | 174 | 0.020 |
Why?
|
Propylamines | 2 | 1983 | 161 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2850 | 0.020 |
Why?
|
Monoamine Oxidase Inhibitors | 2 | 1981 | 156 | 0.020 |
Why?
|
Antisocial Personality Disorder | 2 | 1989 | 224 | 0.020 |
Why?
|
Time Factors | 12 | 2006 | 39969 | 0.020 |
Why?
|
Receptors, Opioid | 1 | 1991 | 145 | 0.020 |
Why?
|
Agoraphobia | 2 | 1988 | 177 | 0.020 |
Why?
|
Fluoxetine | 1 | 1993 | 733 | 0.020 |
Why?
|
Triiodothyronine | 1 | 1991 | 493 | 0.020 |
Why?
|
Pituitary Gland, Posterior | 1 | 1989 | 42 | 0.020 |
Why?
|
Oxytocin | 2 | 1990 | 402 | 0.020 |
Why?
|
Lithium | 4 | 1982 | 596 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 1994 | 1023 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 1995 | 2079 | 0.020 |
Why?
|
Infusions, Intravenous | 2 | 1990 | 2217 | 0.020 |
Why?
|
Cyclic AMP | 2 | 1990 | 1463 | 0.020 |
Why?
|
Health Status | 1 | 2001 | 4077 | 0.020 |
Why?
|
Prednisone | 1 | 1993 | 1563 | 0.020 |
Why?
|
Age Factors | 3 | 1992 | 18399 | 0.020 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1988 | 242 | 0.020 |
Why?
|
Psychometrics | 2 | 1994 | 3065 | 0.020 |
Why?
|
Pro-Opiomelanocortin | 1 | 1987 | 140 | 0.020 |
Why?
|
Clinical Trials as Topic | 6 | 1993 | 8002 | 0.020 |
Why?
|
Mental Recall | 1 | 1993 | 1221 | 0.020 |
Why?
|
Posture | 1 | 1991 | 957 | 0.020 |
Why?
|
Attention | 1 | 2017 | 2396 | 0.020 |
Why?
|
Seasons | 1 | 1992 | 1520 | 0.020 |
Why?
|
Heart Rate | 7 | 1990 | 4195 | 0.020 |
Why?
|
Amenorrhea | 1 | 1990 | 483 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 3 | 1983 | 353 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8181 | 0.020 |
Why?
|
Ultrasonography | 1 | 1999 | 5971 | 0.020 |
Why?
|
Somatostatin | 1 | 1988 | 447 | 0.020 |
Why?
|
Weight Loss | 1 | 2017 | 2684 | 0.020 |
Why?
|
Blood-Brain Barrier | 3 | 1993 | 1027 | 0.020 |
Why?
|
Calcium | 1 | 1979 | 5722 | 0.020 |
Why?
|
Animals | 11 | 2017 | 168475 | 0.020 |
Why?
|
Phobic Disorders | 1 | 1988 | 439 | 0.020 |
Why?
|
Estradiol | 1 | 1992 | 1937 | 0.020 |
Why?
|
Diethylpropion | 1 | 1984 | 1 | 0.020 |
Why?
|
Cyproheptadine | 1 | 1984 | 20 | 0.020 |
Why?
|
Phenylpropanolamine | 1 | 1984 | 15 | 0.020 |
Why?
|
Selegiline | 1 | 1985 | 32 | 0.020 |
Why?
|
Pressoreceptors | 1 | 1985 | 99 | 0.020 |
Why?
|
Phenethylamines | 1 | 1985 | 95 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1991 | 1866 | 0.010 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2004 | 74 | 0.010 |
Why?
|
Pilot Projects | 2 | 1995 | 8633 | 0.010 |
Why?
|
Desipramine | 1 | 1984 | 182 | 0.010 |
Why?
|
Injections, Intraventricular | 1 | 1984 | 225 | 0.010 |
Why?
|
Arecoline | 1 | 1983 | 9 | 0.010 |
Why?
|
Resistin | 1 | 2004 | 172 | 0.010 |
Why?
|
Nonprescription Drugs | 1 | 1984 | 118 | 0.010 |
Why?
|
Receptors, Cholinergic | 1 | 1984 | 244 | 0.010 |
Why?
|
Receptors, Dopamine | 3 | 1980 | 296 | 0.010 |
Why?
|
Medulla Oblongata | 1 | 1985 | 248 | 0.010 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 2 | 1983 | 477 | 0.010 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1985 | 363 | 0.010 |
Why?
|
Receptors, Leptin | 1 | 2004 | 350 | 0.010 |
Why?
|
Pimozide | 2 | 1980 | 21 | 0.010 |
Why?
|
Receptors, Neurotransmitter | 1 | 1983 | 174 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 1984 | 8601 | 0.010 |
Why?
|
Caffeine | 2 | 1984 | 700 | 0.010 |
Why?
|
Ouabain | 1 | 1982 | 247 | 0.010 |
Why?
|
Acetylcholine | 1 | 1984 | 629 | 0.010 |
Why?
|
Carbolines | 1 | 1984 | 296 | 0.010 |
Why?
|
Adipose Tissue | 1 | 1994 | 3313 | 0.010 |
Why?
|
Locus Coeruleus | 1 | 1984 | 230 | 0.010 |
Why?
|
Sleep, REM | 3 | 1980 | 595 | 0.010 |
Why?
|
Prostaglandins E | 1 | 1981 | 166 | 0.010 |
Why?
|
Twins, Dizygotic | 1 | 1982 | 236 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 1993 | 8527 | 0.010 |
Why?
|
Brain Chemistry | 1 | 1985 | 960 | 0.010 |
Why?
|
Hypotension, Orthostatic | 1 | 1984 | 258 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 2004 | 1122 | 0.010 |
Why?
|
Erythrocyte Membrane | 1 | 1982 | 439 | 0.010 |
Why?
|
Functional Laterality | 1 | 2007 | 2257 | 0.010 |
Why?
|
National Institute of Mental Health (U.S.) | 1 | 1981 | 107 | 0.010 |
Why?
|
Macaca mulatta | 2 | 1984 | 2329 | 0.010 |
Why?
|
Choline O-Acetyltransferase | 1 | 1981 | 156 | 0.010 |
Why?
|
Methylphenidate | 1 | 1984 | 488 | 0.010 |
Why?
|
Amphetamine | 1 | 1981 | 224 | 0.010 |
Why?
|
Lymphocytes | 1 | 1988 | 2612 | 0.010 |
Why?
|
Corticosterone | 1 | 1981 | 305 | 0.010 |
Why?
|
Chronic Disease | 3 | 1992 | 9319 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1981 | 2088 | 0.010 |
Why?
|
Genetic Markers | 2 | 1983 | 2601 | 0.010 |
Why?
|
Obesity | 3 | 1994 | 12947 | 0.010 |
Why?
|
Psychoses, Substance-Induced | 1 | 1980 | 99 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 1068 | 0.010 |
Why?
|
Catechol O-Methyltransferase | 1 | 1981 | 251 | 0.010 |
Why?
|
Alcoholism | 1 | 1989 | 1973 | 0.010 |
Why?
|
Hypoglycemia | 1 | 2006 | 883 | 0.010 |
Why?
|
Adiponectin | 1 | 2004 | 1113 | 0.010 |
Why?
|
Premedication | 1 | 1979 | 246 | 0.010 |
Why?
|
Naloxone | 1 | 1981 | 370 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 1978 | 151 | 0.010 |
Why?
|
Electrolytes | 1 | 1979 | 274 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18255 | 0.010 |
Why?
|
Central Nervous System | 1 | 1985 | 1336 | 0.010 |
Why?
|
Behavior | 2 | 1980 | 541 | 0.010 |
Why?
|
Substance-Related Disorders | 2 | 1989 | 4420 | 0.010 |
Why?
|
Octopamine | 1 | 1977 | 43 | 0.010 |
Why?
|
Haplorhini | 1 | 1978 | 525 | 0.010 |
Why?
|
Psychotic Disorders | 2 | 1982 | 3223 | 0.010 |
Why?
|
Species Specificity | 1 | 1981 | 2414 | 0.010 |
Why?
|
Lipids | 1 | 2007 | 3341 | 0.010 |
Why?
|
3-Methoxy-4-hydroxyphenylethanol | 1 | 1976 | 2 | 0.010 |
Why?
|
Indoles | 1 | 1984 | 1833 | 0.010 |
Why?
|
Catechols | 1 | 1976 | 62 | 0.010 |
Why?
|
Central Nervous System Stimulants | 1 | 1984 | 1177 | 0.010 |
Why?
|
Meprobamate | 1 | 1975 | 4 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 1997 | 26129 | 0.010 |
Why?
|
Rats | 4 | 1985 | 23741 | 0.010 |
Why?
|
Personality Disorders | 1 | 1980 | 722 | 0.010 |
Why?
|
Nucleotides, Cyclic | 1 | 1976 | 84 | 0.010 |
Why?
|
Vasopressins | 2 | 1989 | 351 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 1978 | 685 | 0.010 |
Why?
|
Adjustment Disorders | 1 | 1975 | 67 | 0.010 |
Why?
|
Magnesium | 1 | 1979 | 804 | 0.010 |
Why?
|
Lighting | 1 | 1977 | 211 | 0.010 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1980 | 625 | 0.010 |
Why?
|
Schizophrenic Psychology | 1 | 1982 | 1647 | 0.010 |
Why?
|
Anticonvulsants | 1 | 1984 | 1906 | 0.010 |
Why?
|
Complement Factor D | 1 | 1994 | 66 | 0.010 |
Why?
|
Exercise | 1 | 1991 | 5890 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 1981 | 1301 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1989 | 14665 | 0.010 |
Why?
|
Sleep Stages | 1 | 1977 | 694 | 0.010 |
Why?
|
Erythrocytes | 1 | 1982 | 2413 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1989 | 15266 | 0.010 |
Why?
|
Infusions, Parenteral | 2 | 1984 | 397 | 0.010 |
Why?
|
Aged | 9 | 1993 | 169310 | 0.010 |
Why?
|
Treatment Outcome | 3 | 1993 | 64685 | 0.010 |
Why?
|
Caudate Nucleus | 1 | 1973 | 390 | 0.010 |
Why?
|
Electroencephalography | 2 | 1977 | 6237 | 0.010 |
Why?
|
Behavior, Animal | 2 | 1984 | 1878 | 0.010 |
Why?
|
Autonomic Nervous System Diseases | 2 | 1984 | 269 | 0.010 |
Why?
|
Blood Glucose | 1 | 2006 | 6391 | 0.010 |
Why?
|
Suicide | 1 | 1982 | 1602 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 1978 | 2192 | 0.010 |
Why?
|
Indians, North American | 1 | 1994 | 352 | 0.010 |
Why?
|
Blood Platelets | 1 | 1981 | 2479 | 0.010 |
Why?
|
Life Change Events | 2 | 1986 | 952 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2007 | 36426 | 0.010 |
Why?
|
Hemorrhage | 1 | 1981 | 3424 | 0.000 |
Why?
|
Guanylyl Imidodiphosphate | 1 | 1988 | 37 | 0.000 |
Why?
|
Brain Stem | 1 | 1973 | 858 | 0.000 |
Why?
|
beta-Lipotropin | 1 | 1987 | 3 | 0.000 |
Why?
|
Schizophrenia, Paranoid | 1 | 1988 | 103 | 0.000 |
Why?
|
Models, Biological | 1 | 1984 | 9469 | 0.000 |
Why?
|
Neuropeptide Y | 1 | 1989 | 192 | 0.000 |
Why?
|
Pain | 1 | 1982 | 5073 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1989 | 39106 | 0.000 |
Why?
|
Reaction Time | 1 | 1973 | 2089 | 0.000 |
Why?
|
Normetanephrine | 1 | 1986 | 25 | 0.000 |
Why?
|
Thyroid Gland | 1 | 1994 | 1170 | 0.000 |
Why?
|
Metanephrine | 1 | 1986 | 25 | 0.000 |
Why?
|
Aging | 1 | 2006 | 8710 | 0.000 |
Why?
|
Menstrual Cycle | 1 | 1990 | 539 | 0.000 |
Why?
|
Pregnancy | 3 | 1983 | 29890 | 0.000 |
Why?
|
Peptides | 2 | 1993 | 4358 | 0.000 |
Why?
|
Dihydroergotoxine | 1 | 1985 | 21 | 0.000 |
Why?
|
Liver | 1 | 1981 | 7528 | 0.000 |
Why?
|
Acute Disease | 1 | 1975 | 7237 | 0.000 |
Why?
|
Hypertension | 1 | 1985 | 8540 | 0.000 |
Why?
|
Depression, Chemical | 1 | 1984 | 184 | 0.000 |
Why?
|
Tritium | 1 | 1985 | 708 | 0.000 |
Why?
|
Monoamine Oxidase | 1 | 1985 | 181 | 0.000 |
Why?
|
Appetite Depressants | 1 | 1985 | 108 | 0.000 |
Why?
|
Adrenal Medulla | 1 | 1984 | 56 | 0.000 |
Why?
|
Biotransformation | 1 | 1984 | 166 | 0.000 |
Why?
|
Glycopyrrolate | 1 | 1983 | 32 | 0.000 |
Why?
|
Sex Characteristics | 1 | 1994 | 2639 | 0.000 |
Why?
|
Metabolic Clearance Rate | 1 | 1984 | 361 | 0.000 |
Why?
|
Electrochemistry | 1 | 1983 | 145 | 0.000 |
Why?
|
Personality Development | 1 | 1983 | 244 | 0.000 |
Why?
|
Adrenal Gland Diseases | 1 | 1984 | 141 | 0.000 |
Why?
|
Schizoid Personality Disorder | 1 | 1982 | 14 | 0.000 |
Why?
|
Propranolol | 1 | 1984 | 489 | 0.000 |
Why?
|
Thinness | 1 | 1986 | 490 | 0.000 |
Why?
|
Body Fluids | 1 | 1984 | 320 | 0.000 |
Why?
|
Behavior Therapy | 1 | 1988 | 879 | 0.000 |
Why?
|
Motor Activity | 2 | 1984 | 2715 | 0.000 |
Why?
|
Psychophysiologic Disorders | 1 | 1982 | 221 | 0.000 |
Why?
|
Pheochromocytoma | 1 | 1983 | 328 | 0.000 |
Why?
|
Haloperidol | 1 | 1982 | 389 | 0.000 |
Why?
|
Receptors, GABA-A | 1 | 1984 | 623 | 0.000 |
Why?
|
Reference Standards | 1 | 1983 | 1003 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1988 | 80647 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1983 | 1541 | 0.000 |
Why?
|
Psychiatry | 1 | 1992 | 1693 | 0.000 |
Why?
|
Insulin | 1 | 1994 | 6597 | 0.000 |
Why?
|
Atrophy | 1 | 1984 | 1633 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1992 | 3600 | 0.000 |
Why?
|
Ligands | 1 | 1984 | 3272 | 0.000 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1983 | 732 | 0.000 |
Why?
|
Random Allocation | 1 | 1981 | 2395 | 0.000 |
Why?
|
Imipramine | 1 | 1976 | 98 | 0.000 |
Why?
|
Remission, Spontaneous | 1 | 1977 | 384 | 0.000 |
Why?
|
Amitriptyline | 1 | 1976 | 112 | 0.000 |
Why?
|
Kinetics | 1 | 1984 | 6374 | 0.000 |
Why?
|
Recurrence | 1 | 1988 | 8466 | 0.000 |
Why?
|
Glucose | 1 | 1987 | 4347 | 0.000 |
Why?
|
Research | 1 | 1983 | 1982 | 0.000 |
Why?
|
Borderline Personality Disorder | 1 | 1982 | 768 | 0.000 |
Why?
|
Disorders of Excessive Somnolence | 1 | 1977 | 277 | 0.000 |
Why?
|
United States | 1 | 1981 | 72340 | 0.000 |
Why?
|
Light | 1 | 1978 | 1353 | 0.000 |
Why?
|
Risk | 1 | 1983 | 9610 | 0.000 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 1977 | 1081 | 0.000 |
Why?
|
Nervous System Diseases | 1 | 1978 | 1667 | 0.000 |
Why?
|
Hemodynamics | 1 | 1977 | 4160 | 0.000 |
Why?
|
Antipsychotic Agents | 1 | 1979 | 3067 | 0.000 |
Why?
|
Sleep | 1 | 1977 | 4768 | 0.000 |
Why?
|